Clene (CLNN) Research & Development (2020 - 2026)
Clene (CLNN) recorded Research & Development of $3.47 million in Q2 2026, down 1.2% from $3.51 million a year earlier.
Powered by 
Analysis
Clene (CLNN) Research & Development (2020 - 2026) Analysis & Trends
On a TTM basis, Clene's Research & Development came in at $16 million as of Jun 30, 2026, up 6.4% year-over-year; for FY2025, it was $14.01 million, down 30.1% from FY2024.
- Annual Research & Development has declined for three straight years, with a five-year compound annual growth rate of -1.6% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $20.06 million in FY2024 (-24.7%), $26.66 million in FY2023 (-16.5%), $31.92 million in FY2022 (+12.3%) and $28.42 million in FY2021 (+86.9%).
- The Q2 2026 figure is the lowest quarterly Research & Development since Q1 2025.
- Peak year-over-year performance for Research & Development in the last five years was growth of 113.8% in Q4 2021, against a decline of 74.8% in Q1 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Clene | 62.68 Mn | 32.00 Mn | 40,000.00 | 4.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.45 Mn |
| Jun 30, 2026 | 3.47 Mn |
| Mar 31, 2026 | 329,000.00 |
| Dec 31, 2025 | 5.50 Mn |
| Sep 30, 2025 | 3.51 Mn |
| Jun 30, 2025 | 3.51 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 5.57 Mn |
| Sep 30, 2024 | 4.47 Mn |
| Jun 30, 2024 | 4.15 Mn |
| Mar 31, 2024 | 5.87 Mn |
| Dec 31, 2023 | 6.67 Mn |
| Sep 30, 2023 | 5.97 Mn |
| Jun 30, 2023 | 6.62 Mn |
| Mar 31, 2023 | 7.40 Mn |
| Dec 31, 2022 | 7.77 Mn |
| Sep 30, 2022 | 6.40 Mn |
| Jun 30, 2022 | 9.17 Mn |
| Mar 31, 2022 | 8.58 Mn |
| Dec 31, 2021 | 9.52 Mn |
API Access
Clene Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CLNN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CLNN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CLNN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();